New Drug Application (NDA) Submission of Reproxalap for the Treatment of Dry Eye Disease on Schedule for the Fourth Quarter of 2022 Pre-NDA Meeting with the U.S. Food and Drug Administration (FDA) Scheduled for the Fourth Quarter of 2022 to Discuss NDA Submission of ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma Top-Line Results from … [Read more…]
Established Cape Town office will significantly grow staff AUSTIN, Texas–(BUSINESS WIRE)–SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s … [Read more…]
-Roger Dansey, M.D., Appointed President, Research and Development – BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that its Board of Directors has appointed David R. Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors. Mr. Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more … [Read more…]
CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its third quarter ended September 30, 2022, and updated financial expectations for the full year ending December 31, 2022. Third Quarter 2022 Financial Summary: Total revenue of … [Read more…]
LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in a fireside chat during the upcoming Stifel 2022 Healthcare investor conference on Wednesday, November 16, 2022 at 8:00 a.m. … [Read more…]
Third quarter revenue grew 3.9x year-over-year to $288.9 million U.S. value-based care members grew by 171% year-over-year, including 285% growth in Medicare membership Adjusted EBITDA Margin of (18.8)% for the quarter (equivalent to $(18.1) million Adjusted EBITDA per month), a 45 percentage points improvement year-over-year, reflecting successful execution of cost reduction actions Partnering with Ambetter … [Read more…]
GATWICK, England–(BUSINESS WIRE)–This material is intended for UK medical and pharmaceutical trade media only. For journalistic assessment and preparation before publication. People living with diabetes in the UK who use Abbott’s FreeStyle LibreLink app with FreeStyle Libre glucose sensing technology*, can now connect it to Novo Nordisk’s smart connected pens. This allows people living with … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Cardiac Rehabilitation Market Size, Share & Industry Trends Analysis Report By Product (Treadmill, Elliptical Trainer, Rower, Stabilization Ball, Heart Rate Monitor, Blood Pressure Monitor), By End User, By Disease Type, By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Cardiac Rehabilitation Market size is … [Read more…]
Almirall achieves core net sales of €633.8 MM Euros in the first nine months of 2022 showing a solid 5.3% growth Almirall continues solid business momentum in Q3 with an acceleration of sales growth (+5.3% year-on-year) driven by the recently launched products and the strong performance of the European Dermatology portfolio Excellent momentum of the … [Read more…]
Data from all nine participants in STIMO trial published in Nature Researchers identify specific neurons activated and remodeled by spinal cord stimulation that enable patients to walk EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people … [Read more…]
